CN104592222B - 抗血小板药物azd6482的制备方法 - Google Patents
抗血小板药物azd6482的制备方法 Download PDFInfo
- Publication number
- CN104592222B CN104592222B CN201410828556.XA CN201410828556A CN104592222B CN 104592222 B CN104592222 B CN 104592222B CN 201410828556 A CN201410828556 A CN 201410828556A CN 104592222 B CN104592222 B CN 104592222B
- Authority
- CN
- China
- Prior art keywords
- reaction
- methyl
- azd6482
- preparation
- acetyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCC(C1=CC(*C)=CN2C1=NC(N1CCOCC1)=CC2=O)=* Chemical compound CCC(C1=CC(*C)=CN2C1=NC(N1CCOCC1)=CC2=O)=* 0.000 description 4
- XEQKAKYIVJCQCZ-UHFFFAOYSA-N O=C(CC(N1CC=[O]CC1)=O)N1CCOCC1 Chemical compound O=C(CC(N1CC=[O]CC1)=O)N1CCOCC1 XEQKAKYIVJCQCZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410828556.XA CN104592222B (zh) | 2014-12-26 | 2014-12-26 | 抗血小板药物azd6482的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410828556.XA CN104592222B (zh) | 2014-12-26 | 2014-12-26 | 抗血小板药物azd6482的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104592222A CN104592222A (zh) | 2015-05-06 |
CN104592222B true CN104592222B (zh) | 2016-08-24 |
Family
ID=53118322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410828556.XA Active CN104592222B (zh) | 2014-12-26 | 2014-12-26 | 抗血小板药物azd6482的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104592222B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111471001B (zh) * | 2020-05-20 | 2023-05-26 | 上海鲲博玖瑞医药科技发展有限公司 | 4-[(1r)-1-氨基-2-羟基乙基]-3-氟-苯腈的制备方法 |
CN111763176A (zh) * | 2020-07-10 | 2020-10-13 | 常州制药厂有限公司 | 一种GnRH受体拮抗剂关键中间体及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2495661C (en) * | 2002-08-16 | 2011-06-14 | Kinacia Pty Ltd. | Inhibition of phosphoinositide 3-kinase beta |
WO2009093972A1 (en) * | 2008-01-25 | 2009-07-30 | Astrazeneca Ab | Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
-
2014
- 2014-12-26 CN CN201410828556.XA patent/CN104592222B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104592222A (zh) | 2015-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2687510B1 (en) | Method for preparing 2,3-dichloropyridine | |
CN104447445B (zh) | 一种合成阿普斯特中间体的制备方法 | |
KR102230628B1 (ko) | 보르티옥세틴 제조 방법 | |
KR101501856B1 (ko) | 프로판-1-설폰산{3-[5-(4-클로로-페닐)-1H-피롤로[2,3-b]피리딘-3-카본일]-2,4-다이플루오로-페닐}-아마이드의 신규 제조 방법 | |
CN105566215B (zh) | 一种瑞戈非尼的制备方法 | |
CN112062767B (zh) | 一种卢美哌隆的制备方法及其中间体 | |
CN104098553B (zh) | 替格瑞洛的中间体及其制备方法和替格瑞洛的制备方法 | |
JP2022508494A (ja) | モルホリノキナゾリン化合物の製造方法及びその中間体 | |
Shi et al. | General rhodium-catalyzed oxidative cross-coupling reactions between anilines: synthesis of unsymmetrical 2, 2′-diaminobiaryls | |
CN105198821B (zh) | 洛昔替尼的制备方法 | |
JP5791825B2 (ja) | 1−(2−フルオロベンジル)−1H−ピラゾロ[3,4−b]ピリジン−3−ホルムアミジン塩酸塩の合成方法 | |
CN104592222B (zh) | 抗血小板药物azd6482的制备方法 | |
CN104447620B (zh) | 1-[3-[3-(4-氯苯基)丙氧基]丙基]-哌啶盐酸盐的制备方法 | |
CN107540678B (zh) | 一种分子内交叉脱氢偶联制备香豆素并杂芳环类化合物及其衍生物的方法 | |
CN102503883A (zh) | 选择性制备异吲哚啉-1-酮衍生物或异喹啉-1-酮衍生物的方法 | |
CN105237458A (zh) | 一种多取代吲哚衍生物的制备方法 | |
CN105536873B (zh) | 一种复合催化剂及其应用 | |
CN108484508B (zh) | 一种5-三氟甲基尿嘧啶的合成方法 | |
CN104774202B (zh) | 一种9H-吡啶并[2,3-b]吲哚类化合物的合成方法 | |
CN104496995A (zh) | 制备3-乙炔基咪唑并[1,2-b]哒嗪的方法 | |
CN105315184A (zh) | 一种沃替西汀的制备方法及其中间体 | |
CN107935913B (zh) | 咔唑类化合物及其合成方法和应用 | |
CN107383058B (zh) | 马波沙星的制备 | |
CN109517003A (zh) | 一种克瑞沙硼的制备方法 | |
CN105777743A (zh) | 一种吡唑并[3,4-b]吡啶类化合物中间体的制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200515 Address after: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee after: Nanjing Zhiwu Intelligent Technology Co., Ltd Address before: 215000 Jiangsu Province, Suzhou City Industrial Park Commercial Plaza Building 1 room 1305 Lianfeng Patentee before: SUZHOU MIRACPHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200930 Address after: 244000 Babai Road, Yian Economic Development Zone, Tongling City, Anhui Province Patentee after: Tongling Chuang Chuang hi tech creation Co.,Ltd. Address before: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee before: Nanjing Zhiwu Intelligent Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |